Pregabalin Zentiva

Country: Kesatuan Eropah

Bahasa: Inggeris

Sumber: EMA (European Medicines Agency)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
19-03-2024
Ciri produk Ciri produk (SPC)
19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
27-07-2015

Bahan aktif:

pregabalin

Boleh didapati daripada:

Zentiva, k.s.

Kod ATC:

N03AX16

INN (Nama Antarabangsa):

pregabalin

Kumpulan terapeutik:

Antiepileptics,

Kawasan terapeutik:

Anxiety Disorders; Epilepsy

Tanda-tanda terapeutik:

Neuropathic pain , Pregabalin Zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , Epilepsy , Pregabalin Zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , Generalised anxiety disorder , Pregabalin Zentiva is indicated for the treatment of generalised anxiety disorder (GAD) in adults.

Ringkasan produk:

Revision: 15

Status kebenaran:

Authorised

Tarikh kebenaran:

2015-07-17

Risalah maklumat

                                58
B. PACKAGE LEAFLET
59
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN ZENTIVA 25 MG HARD CAPSULES
PREGABALIN ZENTIVA 50 MG HARD CAPSULES
PREGABALIN ZENTIVA 75 MG HARD CAPSULES
PREGABALIN ZENTIVA 100 MG HARD CAPSULES
PREGABALIN ZENTIVA 150 MG HARD CAPSULES
PREGABALIN ZENTIVA 200 MG HARD CAPSULES
PREGABALIN ZENTIVA 225 MG HARD CAPSULES
PREGABALIN ZENTIVA 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Pregabalin Zentiva is and what it is used for
2.
What you need to know before you take Pregabalin Zentiva
3.
How to take Pregabalin Zentiva
4.
Possible side effects
5.
How to store Pregabalin Zentiva
6.
Contents of the pack and other information
1.
WHAT PREGABALIN ZENTIVA IS AND WHAT IT IS USED FOR
Pregabalin Zentiva belongs to a group of medicines used to treat
epilepsy, neuropathic pain
and generalised anxiety disorder (GAD) in adults.
PERIPHERAL AND CENTRAL NEUROPATHIC PAIN
Pregabalin Zentiva is used to treat long lasting pain caused by damage
to the nerves. A variety
of diseases can cause peripheral neuropathic pain, such as diabetes or
shingles. Pain sensations may
be described as hot, burning, throbbing, shooting, stabbing, sharp,
cramping, aching, tingling,
numbness, pins and needles. Peripheral and central neuropathic pain
may also be associated with
mood changes, sleep disturbance, fatigue (tiredness), and can have an
impact on physical and social
functioning and overall quality of life.
EPILEPSY
Pregabalin Zentiva is used to treat a certain form of ep
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Zentiva 25 mg hard capsules
Pregabalin Zentiva 50 mg hard capsules
Pregabalin Zentiva 75 mg hard capsules
Pregabalin Zentiva 100 mg hard capsules
Pregabalin Zentiva 150 mg hard capsules
Pregabalin Zentiva 200 mg hard capsules
Pregabalin Zentiva 225 mg hard capsules
Pregabalin Zentiva 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Zentiva 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 47.57 mg lactose monohydrate.
Pregabalin Zentiva 50 mg hard capsules
Each hard capsule contains 50 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 5 mg lactose monohydrate.
Pregabalin Zentiva 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 7.5 mg lactose monohydrate.
Pregabalin Zentiva 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 10 mg lactose monohydrate.
Pregabalin Zentiva 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 15 mg lactose monohydrate.
Pregabalin Zentiva 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 20 mg lactose monohydrate.
Pregabalin Zentiva 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
3
Excipient with known effect
Each hard capsule also contains 22.5 mg lactose monohydrate.
Pregabalin Zentiva 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 30 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsules
Pregabalin Zentiva 25 mg hard capsules
Light grey cap and light grey body; approx. 15,9 mm in length, hard
gela
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bulgaria 19-03-2024
Ciri produk Ciri produk Bulgaria 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Bulgaria 27-07-2015
Risalah maklumat Risalah maklumat Sepanyol 19-03-2024
Ciri produk Ciri produk Sepanyol 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Sepanyol 27-07-2015
Risalah maklumat Risalah maklumat Czech 19-03-2024
Ciri produk Ciri produk Czech 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Czech 27-07-2015
Risalah maklumat Risalah maklumat Denmark 19-03-2024
Ciri produk Ciri produk Denmark 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Denmark 27-07-2015
Risalah maklumat Risalah maklumat Jerman 19-03-2024
Ciri produk Ciri produk Jerman 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Jerman 27-07-2015
Risalah maklumat Risalah maklumat Estonia 19-03-2024
Ciri produk Ciri produk Estonia 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Estonia 27-07-2015
Risalah maklumat Risalah maklumat Greek 19-03-2024
Ciri produk Ciri produk Greek 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Greek 27-07-2015
Risalah maklumat Risalah maklumat Perancis 19-03-2024
Ciri produk Ciri produk Perancis 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Perancis 27-07-2015
Risalah maklumat Risalah maklumat Itali 19-03-2024
Ciri produk Ciri produk Itali 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Itali 27-07-2015
Risalah maklumat Risalah maklumat Latvia 19-03-2024
Ciri produk Ciri produk Latvia 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Latvia 27-07-2015
Risalah maklumat Risalah maklumat Lithuania 19-03-2024
Ciri produk Ciri produk Lithuania 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Lithuania 27-07-2015
Risalah maklumat Risalah maklumat Hungary 19-03-2024
Ciri produk Ciri produk Hungary 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Hungary 27-07-2015
Risalah maklumat Risalah maklumat Malta 19-03-2024
Ciri produk Ciri produk Malta 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Malta 27-07-2015
Risalah maklumat Risalah maklumat Belanda 19-03-2024
Ciri produk Ciri produk Belanda 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Belanda 27-07-2015
Risalah maklumat Risalah maklumat Poland 19-03-2024
Ciri produk Ciri produk Poland 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Poland 27-07-2015
Risalah maklumat Risalah maklumat Portugis 19-03-2024
Ciri produk Ciri produk Portugis 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Portugis 27-07-2015
Risalah maklumat Risalah maklumat Romania 19-03-2024
Ciri produk Ciri produk Romania 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Romania 27-07-2015
Risalah maklumat Risalah maklumat Slovak 19-03-2024
Ciri produk Ciri produk Slovak 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Slovak 27-07-2015
Risalah maklumat Risalah maklumat Slovenia 19-03-2024
Ciri produk Ciri produk Slovenia 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Slovenia 27-07-2015
Risalah maklumat Risalah maklumat Finland 19-03-2024
Ciri produk Ciri produk Finland 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Finland 27-07-2015
Risalah maklumat Risalah maklumat Sweden 19-03-2024
Ciri produk Ciri produk Sweden 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Sweden 27-07-2015
Risalah maklumat Risalah maklumat Norway 19-03-2024
Ciri produk Ciri produk Norway 19-03-2024
Risalah maklumat Risalah maklumat Iceland 19-03-2024
Ciri produk Ciri produk Iceland 19-03-2024
Risalah maklumat Risalah maklumat Croat 19-03-2024
Ciri produk Ciri produk Croat 19-03-2024
Laporan Penilaian Awam Laporan Penilaian Awam Croat 27-07-2015

Cari amaran yang berkaitan dengan produk ini